Ras-Related Associated with Diabetes (RRAD) (Middle Region) Peptide
RRAD
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN983275
Quick Overview for Ras-Related Associated with Diabetes (RRAD) (Middle Region) Peptide (ABIN983275)
Target
RRAD
(Ras-Related Associated with Diabetes (RRAD))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RRAD antibody (Catalog #: ARP56566_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RRAD (Ras-Related Associated with Diabetes (RRAD))
-
Background
-
RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. RRAD regulates voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. RRAD inhibits cardiac hy
Alias Symbols: RAD, RAD1, REM3
Protein Interaction Partner: CALM1,CAMK2G,CSNK2A1,NME1,PRKACA,PRKCA,PRKCB,TPM2,YWHAZ,CAMK2G,NME1,TPM2,Tpm2,YWHAZ
Protein Size: 308 -
Molecular Weight
- 33 kDa
-
Gene ID
- 6236
-
NCBI Accession
- NM_004165, NP_004156
-
UniProt
- P55042
Target
-
You are here:
